+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Enzyme-linked Immunosorbent Assay Testing Market Research Report by Test Type, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 259 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989693
UP TO OFF until Dec 31st 2022
The Global Enzyme-linked Immunosorbent Assay Testing Market size was estimated at USD 452.02 million in 2021, USD 482.85 million in 2022, and is projected to grow at a CAGR of 6.99% to reach USD 678.28 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Enzyme-linked Immunosorbent Assay Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Test Type, the market was studied across Competitive ELISA, Indirect ELISA, Multiple and Portable ELISA, and Sandwich ELISA.
  • Based on Application, the market was studied across Cancer, Immunology, Infectious Diseases, Inflammation, and Protein Quantitation.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Enzyme-linked Immunosorbent Assay Testing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Enzyme-linked Immunosorbent Assay Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Enzyme-linked Immunosorbent Assay Testing Market, including Abcam, Agilent Technologies Inc., BD, Bio-Rad Laboratories, bioMérieux, Life Technologies Corporation, Ortho Clinical Diagnostics Inc., Thermo Fisher Scientific, Thermo Fisher Scientific. Inc., and ZEUS Scientific, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Enzyme-linked Immunosorbent Assay Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Enzyme-linked Immunosorbent Assay Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Enzyme-linked Immunosorbent Assay Testing Market?
4. What is the competitive strategic window for opportunities in the Global Enzyme-linked Immunosorbent Assay Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Enzyme-linked Immunosorbent Assay Testing Market?
6. What is the market share of the leading vendors in the Global Enzyme-linked Immunosorbent Assay Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Enzyme-linked Immunosorbent Assay Testing Market?
Frequently Asked Questions about the Global Enzyme-linked Immunosorbent Assay Testing Market

What is the estimated value of the Global Enzyme-linked Immunosorbent Assay Testing Market?

The Global Enzyme-linked Immunosorbent Assay Testing Market was estimated to be valued at $452.02 Million in 2021.

What is the growth rate of the Global Enzyme-linked Immunosorbent Assay Testing Market?

The growth rate of the Global Enzyme-linked Immunosorbent Assay Testing Market is 6.9%, with an estimated value of $678.28 Million by 2027.

What is the forecasted size of the Global Enzyme-linked Immunosorbent Assay Testing Market?

The Global Enzyme-linked Immunosorbent Assay Testing Market is estimated to be worth $678.28 Million by 2027.

Who are the key companies in the Global Enzyme-linked Immunosorbent Assay Testing Market?

Key companies in the Global Enzyme-linked Immunosorbent Assay Testing Market include Abcam, Agilent Technologies Inc., BD, Bio, Rad Laboratories, bioMérieux, Life Technologies Corporation, Ortho Clinical Diagnostics Inc. and Thermo Fisher Scientific. Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence rate of infectious diseases
5.1.1.2. Need for cost-effective diagnostic tools
5.1.2. Restraints
5.1.2.1. ELISA is not suitable for high-throughput screening and analysis
5.1.3. Opportunities
5.1.3.1. Ongoing developments and launches of the ELISA testing
5.1.3.2. Potential growth for low-cost portable ELISA reader based on image analysis
5.1.4. Challenges
5.1.4.1. Complex assay development workflows
5.2. Cumulative Impact of COVID-19
6. Enzyme-linked Immunosorbent Assay Testing Market, by Test Type
6.1. Introduction
6.2. Competitive ELISA
6.3. Indirect ELISA
6.4. Multiple and Portable ELISA
6.5. Sandwich ELISA
7. Enzyme-linked Immunosorbent Assay Testing Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Immunology
7.4. Infectious Diseases
7.5. Inflammation
7.6. Protein Quantitation
8. Americas Enzyme-linked Immunosorbent Assay Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Enzyme-linked Immunosorbent Assay Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Enzyme-linked Immunosorbent Assay Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Abcam
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. Agilent Technologies Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. BD
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Bio-Rad Laboratories
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. bioMérieux
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Life Technologies Corporation
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Ortho Clinical Diagnostics Inc.
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Thermo Fisher Scientific
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. Thermo Fisher Scientific. Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. ZEUS Scientific, Inc.
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET DYNAMICS
FIGURE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST TYPE, 2027
FIGURE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE AND PORTABLE ELISA, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, 2018-2027 (USD MILLION)
FIGURE 26. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 27. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 28. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 29. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 30. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 36. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 38. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 40. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 41. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 42. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 45. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 46. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 49. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 50. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 58. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 80. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 81. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE AND PORTABLE ELISA, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE AND PORTABLE ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY MULTIPLE AND PORTABLE ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INFLAMMATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PROTEIN QUANTITATION, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 36. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 37. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 38. AMERICAS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 39. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 40. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 41. ARGENTINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 42. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 44. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 45. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 46. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 47. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 48. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 50. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 51. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 52. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 53. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 54. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 57. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 59. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 61. AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 62. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 63. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 64. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 65. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 66. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 67. INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 68. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 69. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 70. INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 71. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 73. JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 74. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 75. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 76. MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 77. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 78. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 79. PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 80. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 82. SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 83. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 84. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 85. SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 88. TAIWAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 89. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 91. THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 92. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 93. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 94. VIETNAM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 99. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 100. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 101. DENMARK ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 102. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 104. EGYPT ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 105. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 106. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 107. FINLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 108. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 109. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 110. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 111. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 113. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 114. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 115. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 116. ISRAEL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 117. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 119. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 120. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 122. NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 123. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 125. NIGERIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 126. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 128. NORWAY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 129. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 131. POLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 132. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 134. QATAR ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 135. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 137. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 138. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 140. SAUDI ARABIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 141. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 143. SOUTH AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 144. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 146. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 147. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 149. SWEDEN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 150. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 151. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 152. SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 153. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 154. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 155. TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 159. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 160. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY TEST TYPE, 2018-2027 (USD MILLION)
TABLE 161. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 162. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 163. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 164. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 165. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET RANKING, BY KEY PLAYER, 2021
TABLE 166. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 167. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET MERGER & ACQUISITION
TABLE 168. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 169. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 170. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET INVESTMENT & FUNDING
TABLE 171. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 172. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abcam
  • Agilent Technologies Inc.
  • BD
  • Bio-Rad Laboratories
  • bioMérieux
  • Life Technologies Corporation
  • Ortho Clinical Diagnostics Inc.
  • Thermo Fisher Scientific
  • Thermo Fisher Scientific. Inc.
  • ZEUS Scientific, Inc.

Methodology

Loading
LOADING...